Blood Cancer Journal (Feb 2023)
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry
- Somayya Noori,
- Charissa Wijnands,
- Pieter Langerhorst,
- Vincent Bonifay,
- Christoph Stingl,
- Cyrille Touzeau,
- Jill Corre,
- Aurore Perrot,
- Philippe Moreau,
- Hélène Caillon,
- Theo M. Luider,
- Thomas Dejoie,
- Joannes F. M. Jacobs,
- Martijn M. van Duijn
Affiliations
- Somayya Noori
- Department of Neurology, Erasmus University Medical Center
- Charissa Wijnands
- Department of Laboratory Medicine, Radboud University Medical Center
- Pieter Langerhorst
- Department of Laboratory Medicine, Radboud University Medical Center
- Vincent Bonifay
- Sebia
- Christoph Stingl
- Department of Neurology, Erasmus University Medical Center
- Cyrille Touzeau
- Centre Hospitalier Universitaire de Nantes
- Jill Corre
- Unite de Genomique du Myelome, Institut Universitaire du Cancer de Toulouse-Oncopole
- Aurore Perrot
- Institut Universitaire du Cancer de Toulouse-Oncopole
- Philippe Moreau
- Hematology, University Hospital Hôtel-Dieu
- Hélène Caillon
- Biochemistry Laboratory, Hospital of Nantes
- Theo M. Luider
- Department of Neurology, Erasmus University Medical Center
- Thomas Dejoie
- Biochemistry Laboratory, Hospital of Nantes
- Joannes F. M. Jacobs
- Department of Laboratory Medicine, Radboud University Medical Center
- Martijn M. van Duijn
- Department of Neurology, Erasmus University Medical Center
- DOI
- https://doi.org/10.1038/s41408-023-00803-z
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 3
Abstract
No abstracts available.